Optimal Patient Positioning for Erector Spinae Plane Block in Laparoscopic Cholecystectomy:

NCT ID: NCT07018258

Last Updated: 2025-11-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-06-27

Study Completion Date

2025-12-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This randomized clinical study aims to compare the postoperative analgesic efficacy, analgesic consumption, and patient satisfaction of erector spinae plane (ESP) block administered in three different patient positions-lateral, prone, and sitting-in individuals undergoing elective laparoscopic cholecystectomy. The study also evaluates the variation in skin-to-block site distance depending on patient positioning.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Erector spinae plane (ESP) block is a relatively recent regional anesthesia technique performed under ultrasound guidance, widely used for managing acute postoperative pain. While the ESP block is known for its safety, simplicity, and versatility, there is limited evidence regarding the influence of patient positioning on its clinical effectiveness and technical performance.

This prospective, randomized, single-blind study investigates the impact of administering bilateral ESP block at the T7 vertebral level in three different patient positions: lateral decubitus, prone, and sitting. The study includes adult patients (aged 18-65, ASA I-II) undergoing elective laparoscopic cholecystectomy under general anesthesia.

Primary outcomes include postoperative pain scores (VAS and NRS). Secondary outcomes include total rescue analgesic consumption (tramadol), time to first analgesic requirement, patient satisfaction scores (Likert scale), and measurement of the skin-to-block site distance across different positions. Data will be collected at defined intervals up to 24 hours postoperatively.

The findings are expected to inform clinicians on the optimal patient positioning for ESP block to enhance block efficacy and patient comfort during laparoscopic abdominal surgery.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Postoperative Pain Laparoscopic Cholecystectomy Anesthesia, Regional Pain Management

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Patients will be randomly assigned to receive ESP block in either the lateral, prone, or sitting position prior to laparoscopic cholecystectomy.
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors
The person evaluating postoperative pain scores and satisfaction will be blinded to group assignment.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Lateral Position Group

Patients in this group will receive bilateral erector spinae plane (ESP) block at the T7 level in the lateral decubitus position under ultrasound guidance before laparoscopic cholecystectomy.

Group Type EXPERIMENTAL

Erector Spinae Plane (ESP) Block

Intervention Type PROCEDURE

Ultrasound-guided bilateral erector spinae plane (ESP) block performed at the T7 vertebral level. The intervention will be applied in three different patient positions-lateral, prone, or sitting-prior to laparoscopic cholecystectomy.

Prone Position Group

Patients in this group will receive bilateral erector spinae plane (ESP) block at the T7 level in the lateral decubitus position under ultrasound guidance before laparoscopic cholecystectomy.

Group Type EXPERIMENTAL

Erector Spinae Plane (ESP) Block

Intervention Type PROCEDURE

Ultrasound-guided bilateral erector spinae plane (ESP) block performed at the T7 vertebral level. The intervention will be applied in three different patient positions-lateral, prone, or sitting-prior to laparoscopic cholecystectomy.

Sitting Position Group

Patients in this group will receive bilateral erector spinae plane (ESP) block at the T7 level in the lateral decubitus position under ultrasound guidance before laparoscopic cholecystectomy.

Group Type EXPERIMENTAL

Erector Spinae Plane (ESP) Block

Intervention Type PROCEDURE

Ultrasound-guided bilateral erector spinae plane (ESP) block performed at the T7 vertebral level. The intervention will be applied in three different patient positions-lateral, prone, or sitting-prior to laparoscopic cholecystectomy.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Erector Spinae Plane (ESP) Block

Ultrasound-guided bilateral erector spinae plane (ESP) block performed at the T7 vertebral level. The intervention will be applied in three different patient positions-lateral, prone, or sitting-prior to laparoscopic cholecystectomy.

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Ultrasound-guided ESP block

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age between 18 and 65 years
* Scheduled for elective laparoscopic cholecystectomy
* ASA physical status I-II
* Ability to understand and provide written informed consent

Exclusion Criteria

* Allergy to local anesthetics
* History of chronic opioid use or substance abuse
* Coagulopathy or current anticoagulant therapy
* Local infection at the block site
* Severe spinal deformities or scoliosis
* BMI \> 35 kg/m²
* Pregnancy or breastfeeding
* Refusal to participate in the study
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Harran University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Veli Fahri Pehlivan

Assistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Veli F Pehlivan, Asiss Prof

Role: PRINCIPAL_INVESTIGATOR

Harran University Faculty of Medicine, Department of Anesthesiology

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Veli Fahri Pehlivan

Sanliurfa, , Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Veli F Pehlivan, Asiss Prof

Role: CONTACT

+905327696566

Cevher Akar, Dr

Role: CONTACT

+905446036040

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Veli Fahri Pehlivan, Asisst Prof

Role: primary

05327696566

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Cevher

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Comparison of ESP Block and STAP Plane Block
NCT06663449 NOT_YET_RECRUITING NA